# Birth Defects Associated With Exposure to Lamotrigine in Pregnancy (EUROCAT)

> **NCT01055327** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 1 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** Lamotrigine monotherapy
- **DRUG:** No anti-epileptic drug exposure
- **DRUG:** Non lamotrigine anti-epileptic drug monotherapy

## Key facts

- **NCT ID:** NCT01055327
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2014-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01055327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01055327, "Birth Defects Associated With Exposure to Lamotrigine in Pregnancy (EUROCAT)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01055327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*